Bestatin, also known as Ubenimex, is a competitive protease inhibitor. It is an inhibitor of aminopeptidase B, leukotriene A4 hydrolase, aminopeptidase N. It is being studied for use in the treatment of acute myelocytic leukemia.
- UC San Diego researchers say they've found an immune system molecule that directly kills chronic lymphocytic leukemia cells without harming healthy ones. The molecule, called a monoclonal antibody, is being readied for human clinical trials in the not-too-distant future, lead researcher Thomas J. Kipps said. Kipps holds the Evelyn and Edwin Tasch Chair in Cancer Research at the UCSD Moores...